Results 191 to 200 of about 112,013 (216)
Some of the next articles are maybe not open access.
Antihypertensive Agents 1962–1968
1969Seven years ago Schlittler, Druey, and Marxer [207] reported on antihypertensive agents in a previous volume of this series. Since this review appeared, research in the field of antihypertensive drugs has made steady progress. Although spectacular breakthroughs — exemplified by such pioneering feats as the discoveries of reserpine, hydralazine ...
A. Marxer, O. Schier
openaire +3 more sources
Efficacy of terazosin as an antihypertensive agent
The American Journal of Medicine, 1986A total of 713 patients with hypertension were evaluated in eight randomized, double-blind, placebo-controlled trials of terazosin administered in single daily doses ranging from 1 to 40 mg. In three of these studies, terazosin or placebo was added to ongoing antihypertensive drug therapy. Patient response was categorized (from excellent to inadequate)
Harriet N. Glassman +3 more
openaire +3 more sources
A 1996 update on antihypertensive agents
Current Opinion in Cardiology, 1996Seven new classes of antihypertensive agents that are currently under development are outlined. Clinical studies of neutral endopeptidase inhibitors and angiotensin II receptor blockers are described. Experimental studies are described involving endothelin inhibitors, and clinical and experimental studies of a new multiple action antihypertensive agent,
openaire +3 more sources
Quinazolinylformamidines and Quinazolinediylbisformamidines as Antihypertensive Agents
Journal of Pharmaceutical Sciences, 1978AbstractAuf dem im Formelschema skizzierten Weg werden die Formamidine und Bisb‐formamidine (II) synthetisiert.
S. A. Jun. Lang +3 more
openaire +4 more sources
The Chemistry of Antihypertensive Agents
1977In accordance with the wishes of the Editor, a chapter on the chemistry of antihypertensive agents precedes the pharmacological chapters. If the author has not succeeded in giving all chemical structures for antihypertensive agents mentioned in subsequent contributions, his only consolation for this failure is the fact that this “Handbuch” is concerned
openaire +2 more sources
A Method for Administering the Antihypertensive Agents
Archives of Internal Medicine, 1956The purpose of antihypertensive drug therapy is to lower the blood pressure safely and within the limits of tolerable side-effects. This attainment, however, requires a technique which is even more specialized than our present-day methods for controlling diabetes. The technique is based on the following principles.
openaire +3 more sources
2003
The therapies available for the effective treatment of hypertension or end-organ complications of hypertension continue to experience almost a geometric growth in their numbers. Such a proliferation of therapies creates a conundrum of sorts for the treating physician.
openaire +2 more sources
The therapies available for the effective treatment of hypertension or end-organ complications of hypertension continue to experience almost a geometric growth in their numbers. Such a proliferation of therapies creates a conundrum of sorts for the treating physician.
openaire +2 more sources
Rilmenidine: A novel antihypertensive agent
The American Journal of Medicine, 1989Rilmenidine is a novel antihypertensive agent related to alpha 2-agonists. Pharmacologic and clinical data concerning efficacy and acceptability of rilmenidine, its effects on physiologic functions, and hypothesis of mechanism of action are described in this report.
openaire +2 more sources